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Abstract
Humans are colonized by thousands of bacterial species, but it is difficult to assess the metabolic and pathogenic potential
of the majority of these because they have yet to be cultured. Here, we characterize an uncultivated vaginal mycoplasma
tightly associated with trichomoniasis that was previously known by its 16S rRNA sequence as ‘‘Mnola.’’ In this study, the
mycoplasma was found almost exclusively in women infected with the sexually transmitted pathogen Trichomonas
vaginalis, but rarely observed in women with no diagnosed disease. The genomes of four strains of this species were
reconstructed using metagenome sequencing and assembly of DNA from four discrete mid-vaginal samples, one of which
was obtained from a pregnant woman with trichomoniasis who delivered prematurely. These bacteria harbor several
putative virulence factors and display unique metabolic strategies. Genes encoding proteins with high similarity to potential
virulence factors include two collagenases, a hemolysin, an O-sialoglycoprotein endopeptidase and a feoB-type ferrous iron
transport system. We propose the name ‘‘Candidatus Mycoplasma girerdii’’ for this potential new pathogen.
Citation: Fettweis JM, Serrano MG, Huang B, Brooks JP, Glascock AL, et al. (2014) An Emerging Mycoplasma Associated with Trichomoniasis, Vaginal Infection and
Disease. PLoS ONE 9(10): e110943. doi:10.1371/journal.pone.0110943
Editor: Mitchell F. Balish, Miami University, United States of America
Received May 2, 2014; Accepted September 26, 2014; Published October 22, 2014
Copyright:  2014 Fettweis et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. The complete genome has been deposited at
NCBI under accession number CP007711.
Funding: This work was supported by several grants from the National Institutes of Health: Grant NHGRI/NIAID 4UH3AI083263, The Vaginal Microbiome: Disease,
Genetics and the Environment, Grant NHGRI/NIDCR/NICHD/NCCAM/ORWH 1U54DE023786-01/8U54HD080784-02 and Grant NIH P60MD002256, VCU NIMHD
Comprehensive Center of Excellence. Sequencing was performed in the Next Generation Sequencing Core of the Nucleic Acids Research Facilities at VCU,
supported in part by funding from NIH/NCI 2P30 CA16059. Sequence analysis was performed with infrastructure and support from the Bioinformatics
Computational Core Laboratories and the Center for High Performance Computing at VCU. Microscopy was performed at the VCU Department of Neurobiology
and Anatomy Microscopy Facility, supported, in part, with funding from NIH-NINDS Center core grant (5P30NS047463). ARW was supported by NIH Grant MH-
20030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: fettweisjm@vcu.edu
Introduction
Application of next-generation sequencing to the study of the
human microbiome is rapidly transforming our understanding of
the diversity of the microbial communities that inhabit the human
body [1]. However, progress towards the identification of specific
microbiome signatures or specific organisms with strong links to
disease states has proven elusive. We characterize a new vaginal
mycoplasma species ‘‘Candidatus Mycoplasma girerdii’’, previ-
ously identified only by its 16S rRNA sequence [2], that exhibits a
strong and unique association with the sexually transmitted
pathogen Trichomonas vaginalis.
Organisms of the Mycoplasma and Ureaplasma genera are
collectively referred to as mycoplasmas. They lack cell walls, have
small genomes and are often dependent on their hosts. Mycoplas-
mas of the female urogenital tract are associated with bacterial
vaginosis (BV), pelvic inflammatory disease, preterm labor and
preterm birth [3,4]. These mycoplasmas are among the most
common organisms to invade the amniotic cavity, and their
carriage is associated with chorioamnionitis in preterm premature
rupture of membranes (PPROM) [5]. Moreover, uncultivated and
uncharacterized bacterial species also invade the amniotic cavity
and likely impact pregnancy outcome [6]. Mycoplasmas can
induce inflammatory cytokines in the host [4], and they are more
prevalent in the vaginal flora of HIV-infected women [7].
Ureaplasmas have been associated with complications during
pregnancy [4], M. genitalium with pelvic inflammatory disease,
cervicitis, endometritis and salpingitis [8], and M. hominis with BV
[3] and trichomoniasis [9,10]. M. genitalium is an emerging
sexually-transmitted infection, which causes nongonococcal ure-
thritis in men. Despite these associations with disease, M. hominis
and Ureaplasma are also common in apparently healthy women.
T. vaginalis causes trichomoniasis, the most common non-viral
sexually transmitted infection worldwide [11]. Trichomoniasis
often accompanies low levels of lactobacilli [12] and BV, and has
been implicated in an array of pregnancy complications [13,14].
Although the extracellular eukaryotic parasite binds to vaginal
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epithelial cells and is hemolytic [15], the mechanisms of its
pathogenesis remain enigmatic.
Martin et al. [2] recently described a 16S rRNA sequence from
an unknown Mycoplasma, which they called ‘‘Mnola’’, in vaginal
secretions and found it to be strongly associated with presence of
T. vaginalis in the study. Shortly thereafter, Costello et al. [16]
reported a phylotype with a 16S rRNA sequence exhibiting,99%
identity to that of the new mycoplasma described herein and by
Martin et al. [2] as a predominant taxon in the oral sample of a
low birth-weight infant (24.5 wks) and speculated it may have been
acquired by vertical transmission during delivery. Hyman et al.
also subsequently identified a partial 16S rRNA sequence from a
vaginal sample of a woman who delivered full term that is 99%
similar to ‘‘Ca. M. girerdii’’ [17]. We independently identified this
phylotype and its association with T. vaginalis, first reported by
Martin et al. In the current work, we confirm and extend the
characterization of this new Mycoplasma using metagenomic
strategies, present the genomic sequences of four independently
identified strains, one of which was isolated from a pregnant
woman who subsequently delivered preterm, and we propose
‘‘Candidatus Mycoplasma girerdii’’ for its name.
Results and Discussion
As part of the Vaginal Human Microbiome Project at Virginia
Commonwealth University, we generated 16S rRNA gene-based
microbiome profiles for 1,361 mid-vaginal samples collected from
women visiting outpatient clinics and an additional 110 samples
collected in a labor and delivery unit [18]. Our analyses revealed a
novel mycoplasma phylotype that represented the most abundant
bacterium observed in 25 mid-vaginal samples (i.e., 25/1,471),
including at least one from a woman who experienced preterm
labor. Twenty-two of these 25 (88%) women had a clinically
diagnosed vaginal infection (Table 1), and all but one of these 22
women for whom vaginal pH was recorded exhibited an elevated
pH value greater than 4.5 (median pH value = 5.8), an indicator of
vaginal dysbiosis. Although microbiome profiles based on 16S
rRNA gene surveys are not always accurate measures of the
proportions of bacterial taxa present in a sample for a variety of
reasons (e.g., biases inherent in DNA extraction, PCR and related
sequencing technologies and variations in the number 16S rRNA
genes per genome in different species), it is clear that this
mycoplasma represents a very abundant taxon in the vaginal
samples collected from these 25 women.
We examined the association between vaginal carriage of the
novel bacterium, even as a minor component of the microbiome,
and common clinically diagnosed vaginal infections. The associ-
ation between ‘‘Ca. M. girerdii’’ and trichomoniasis was highest of
several vaginal organisms of the female urogenital tract with a
relative risk of 20.12 (Table 2). M. hominis, which has previously
been linked with trichomoniasis [9,10], exhibits a much weaker
association with a relative risk of 2.53, likely at least in part due to
its strong association with BV. We did not find ‘‘Ca. M. girerdii’’
to be associated with an elevated relative risk for BV as diagnosed
by Amsel’s criteria [19]. Amsel’s criterion assessment provides a
dichotomous test with a relatively high specificity, but relatively
low sensitivity [20]. BV assessed the Nugent’s Gram-stain criteria
[21] represents the continuum of alterations in vaginal flora. Both
pregnant [22] and non-pregnant [2] women with intermediate
Nugent scores have been reported to be more likely to have
trichomoniasis. While Nugent scores were not recorded in this
study, the 16S rRNA microbiome profiles (Figure S1) are
consistent with the hypothesis that women co-infected with ‘‘Ca.
M. girerdii’’ and T. vaginalis may also be more likely to have
intermediate flora.
We detected ‘‘Ca. M. girerdii’’ at threshold of at least 0.1% of
the 16S profile in 28 of the 63 (44.4%) women with clinically
diagnosed trichomoniasis. We also found the new mollicute at less
than 0.1% of the 16S rRNA threshold in eight additional women
with trichomoniasis. Thus, we were unable to detect ‘‘Ca. M.
girerdii’’ in the 16S rRNA gene profiles of only 27 of the 63
(42.9%) women with clinically defined trichomoniasis. In this
study, trichomoniasis was clinically diagnosed by wet prep
microscopy rather than culture and microbiome profiles were
generated using the V1-V3 hypervariable region of the 16S rRNA
gene rather than the V4-V6 region used by others [2]. Despite
these methodological differences and differences in the study
populations, we confirmed a strong association between the
presence of T. vaginalis and ‘‘Ca. M. girerdii’’ previously reported
as statistically significant (p = 0.026) by Martin et al. [2].
Association of ‘‘Ca. M. girerdii’’ with T. vaginalis
Up to half of all T. vaginalis infections are asymptomatic and
undiagnosed [11]. We performed real-time qRT-PCR on all mid-
vaginal samples positive for ‘‘Ca. M. girerdii’’ and found that 49 of
the 51 (96%) women who carried the mycoplasma at a 1%
threshold by 16S rRNA gene profiling also carry T. vaginalis
(Figure 1A; Table 1). Even at a lower 16S rRNA threshold of
0.1%, 61 of 72 (85%) of women who carried ‘‘Ca. M. girerdii’’
were T. vaginalis positive. Thus, ‘‘Ca. M. girerdii’’ exhibits an
unusually strong correlation with trichomoniasis. We also found
that ‘‘Ca. M. girerdii’’ was associated with both of the previously
described genotypes of T. vaginalis [23,24], type 1 and type 2
(Figure S3), indicating a broad-range association with this
infectious disease. Both T. vaginalis genotypes have been reported
in the HIV-positive women [25]. Additional studies are needed to
determine whether ‘‘Ca. M. girerdii’’ co-infection contributes to
the increased risk of HIV acquisition and transmission or to
adverse pregnancy outcomes associated with trichomoniasis.
Interestingly, of 22 women with no diagnosis who were positive
for ‘‘Ca. M. girerdii’’, 14 were also positive for T. vaginalis
(Table 1). Lactobacillus crispatus is associated with decreased rates
of T. vaginalis infection [12], and we found that the three ‘‘Ca. M.
girerdii’’ positive women with a predominance of L. crispatus were
negative for T. vaginalis (Figures 2 and S1). Thus, although our
data are supportive of a dependent relationship, it appears that
‘‘Ca. M. girerdii’’ may not absolutely require T. vaginalis to
colonize the human vagina. Our data suggest vaginal carriage of
the new mycoplasma is associated with elevated vaginal pH and
African American race (Table 3), risk factors for preterm birth
[26], which are also associated with BV [27] and trichomoniasis
[28]. Given the tight association of the mycoplasma with T.
vaginalis, it is not possible to determine whether the organism is
independently associated with these factors.
Fluorescence in situ hybridization (FISH) on vaginal samples
with a representation of ‘‘Ca. M. girerdii’’ (Figure 1B–E, Figure
S2) showed that the bacterium is prominent in polymicrobial
biofilms sometimes associated with ‘‘clue cells’’ (Figure 1B, 1C,
1E), a characteristic of BV. The mycoplasma was also dispersed
with other bacteria and only occasionally co-localized with T.
vaginalis (Figure 1D). It is not yet clear whether ‘‘Ca. M. girerdii’’
can enter and replicate inside of T. vaginalis like M. hominis [29],
penetrate human cells like M. penetrans [30], or whether the
mycoplasma is strictly extracellular. Given that eight women
carrying the mycoplasma were negative for T. vaginalis (Table 1),
our data suggest ‘‘Ca. M. girerdii’’ is not an obligate symbiont of
the parasite as suggested by Martin et al. [2]. Symbiotically-
Trichomoniasis-Associated Mycoplasma
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Table 1. Characteristics of 73 ‘‘Ca. M. girerdii’’ positive vaginal samples.
VCU_ID
% ‘‘Ca.
M. girerdii’’
qRT-PCR
T. vaginalis
Current clinical
diagnosis Race/ethnicity
Vaginal
pH
T. vaginalis
genotype Dominant taxon
VCU_NT02 99.90 + Trichomoniasis African American 4.4 ND ‘‘Ca. M. girerdii’’
VCU_CD82 99.70 + Trichomoniasis African American 6 2 ‘‘Ca. M. girerdii’’
VCU_LN42 97.50 + Trichomoniasis African American ND 1 ‘‘Ca. M. girerdii’’
VCU_QM60 94.90 + Trichomoniasis African American 5.3 1 ‘‘Ca. M. girerdii’’
VCU_NT41{* 92.90 + Preterm labor and delivery African American 6.5 ND ‘‘Ca. M. girerdii’’
VCU_FQ09 90.60 + Trichomoniasis African American 5.5 2 ‘‘Ca. M. girerdii’’
VCU_NT49 90.40 + None African American 5.6 ND ‘‘Ca. M. girerdii’’
VCU_CT62{ 89.90 + Trichomoniasis Hispanic 6 2 ‘‘Ca. M. girerdii’’
VCU_KH69 88.80 + Trichomoniasis Caucasian 7 1 ‘‘Ca. M. girerdii’’
VCU_GK81 88.00 + Trichomoniasis, Bacterial vaginosis African American 5.8 AMB ‘‘Ca. M. girerdii’’
VCU_NT63 87.30 + Bacterial vaginosis African American 6 ND ‘‘Ca. M. girerdii’’
VCU_NT94 85.00 + Not Available African American ND ND ‘‘Ca. M. girerdii’’
VCU_AM41 84.20 + Trichomoniasis African American 5.8 2 ‘‘Ca. M. girerdii’’
VCU_NT05 82.50 + Yeast infection Other (African) 7 ND ‘‘Ca. M. girerdii’’
VCU_OL06 75.60 + Trichomoniasis African American 7 1 ‘‘Ca. M. girerdii’’
VCU_NT03 73.70 + Bacterial vaginosis African American 7 ND ‘‘Ca. M. girerdii’’
VCU_NT54 60.10 + Trichomoniasis African American ND ND ‘‘Ca. M. girerdii’’
VCU_MP27 59.60 + Trichomoniasis African American 5 1 ‘‘Ca. M. girerdii’’
VCU_NT95 58.80 + None African American 7 ND ‘‘Ca. M. girerdii’’
VCU_BK46 56.10 + Trichomoniasis African American 5.5 2 ‘‘Ca. M. girerdii’’
VCU_NT31 51.50 + Genital warts African American 5 ND ‘‘Ca. M. girerdii’’
VCU_NT27 49.70 + Yeast infection African American 5.5 ND ‘‘Ca. M. girerdii’’
VCU_NT44{ 48.40 + Yeast infection African American 5.5 ND ‘‘Ca. M. girerdii’’
VCU_NT22 46.10 + Bacterial vaginosis African American 5.2 ND ‘‘Ca. M. girerdii’’
VCU_NT71{ 34.90 + None African American 5 ND ‘‘Ca. M. girerdii’’
VCU_RQ481 34.77 + Trichomoniasis African American 5.5 2 Lactobacillus iners
VCU_NT75 28.15 + Bacterial vaginosis African American ND ND NT
VCU_NT96 22.56 + None African American 4.5 ND Lactobacillus iners
VCU_QQ25 17.48 + Trichomoniasis Other (Biracial) 6.5 1 NT
VCU_NT06 14.89 + Bacterial vaginosis African American 5 ND Atopobium vaginae
VCU_NT64 8.63 + None African American 4.4 ND Lactobacillus iners
VCU_NT99 8.03 + None African American ND ND Lactobacillus iners
VCU_VL26 7.90 + Trichomoniasis African American 5.8 AMB Prevotella
VCU_NT771 7.51 + Not Available African American 6.6 ND NT
VCU_IV47 7.20 + Trichomoniasis African American 5 2 Gardnerella
vaginalis
VCU_XN28 5.43 + Trichomoniasis African American 5 AMB NT
VCU_NT61 4.09 + None African American ND ND Lactobacillus iners
VCU_NT50 3.36 + Bacterial vaginosis African American 5 ND Gardnerella
vaginalis
VCU_QR65* 2.98 + Trichomoniasis African American ND AMB Mycoplasma
hominis
VCU_NT29 2.59 + Yeast infection African American 4.5 ND Lactobacillus iners
VCU_NT04 2.21 + Bacterial vaginosis African American 5.8 ND Atopobium vaginae
VCU_NT24 2.08 + Yeast infection Other (Biracial) 5 ND Lactobacillus iners
VCU_NT55* 1.90 2 None African American ND N/A Lactobacillus
crispatus
VCU_SY21 1.76 + Trichomoniasis Hispanic 5.5 2 NT
VCU_GF833 1.64 + Trichomoniasis African American 5.8 1 Prevotella
VCU_NT19 1.59 + Trichomoniasis Not available 6 ND Gardnerella
vaginalis
Trichomoniasis-Associated Mycoplasma
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associated M. hominis and T. vaginalis have recently been shown
to synergistically upregulate the proinflammatory response [31].
Further studies are required to determine whether a symbiotic
relationship between ‘‘Ca. M. girerdii’’ and T. vaginalis may
similarly synergize to influence host response.
Genomic and Phylogenetic Analyses of ‘‘Ca. M. girerdii’’
Our attempts to cultivate ‘‘Ca. M. girerdii’’ have not succeeded.
Therefore, we employed the strategy of assembling whole
metagenome shotgun sequence reads to complete the genome of
a reference strain of this organism. The ,619 kb genome is
,28.6% GC content and features sequences for ,572 putative
proteins, 34 structural RNAs and one predicted CRISPR locus
(Figure 3). Three additional strains from other samples were
similarly assembled and aligned to the reference. Gene synteny
was very high among the four strains, but limited with other
related species (Figure S4). The four strains of ‘‘Ca. M. girerdii’’
exhibited an average of 99.8% nucleotide identity.
The reference genome exhibits irregular GC skews with no
distinctive inversion (Figure 3), which is indicative of the high
genome plasticity that is typical for mycoplasmas and consistent
with the overall lack of synteny with related species. In the
Table 1. Cont.
VCU_ID
% ‘‘Ca.
M. girerdii’’
qRT-PCR
T. vaginalis
Current clinical
diagnosis Race/ethnicity
Vaginal
pH
T. vaginalis
genotype Dominant taxon
VCU_LU24 1.50 + Trichomoniasis, Bacterial vaginosis African American 6.1 1 NT
VCU_NT52 1.40 2 Trichomoniasis African American 5.5 ND Gardnerella
vaginalis
VCU_NT69 1.11 + None (abnormal discharge) African American 4.5 ND Lactobacillus iners
VCU_BN49 1.06 + Trichomoniasis, Bacterial vaginosis African American 5 2 Gardnerella
vaginalis
VCU_NT68 0.97 + None African American ND ND Lactobacillus iners
VCU_NT702 0.93 + None African American 5.8 ND Gardnerella
vaginalis
VCU_NT93 0.92 2 None African American 5.3 N/A Gardnerella
vaginalis
VCU_NT21 0.86 + Yeast infection African American 5 ND Lactobacillus iners
VCU_NT60 0.85 + Trichomoniasis African American 4.4 ND BVAB1
VCU_NT67 0.61 + Yeast infection Caucasian 4 ND Lactobacillus iners
VCU_NT17 0.59 2 None Caucasian 4.4 N/A Lactobacillus
crispatus
VCU_NT81 0.56 2 None African American 5.5 N/A BVAB1
VCU_NT28 0.54 + None African American 4 ND Lactobacillus iners
VCU_NT582 0.44 + None African American 4.5 ND Lactobacillus iners
VCU_NT09 0.40 + None African American 4.6 ND BVAB1
VCU_QN84 0.39 + Trichomoniasis African American 6.1 AMB BVAB1
VCU_NT59 0.34 2 None Hispanic ND N/A Lactobacillus iners
VCU_NT97 0.29 2 None African American ND N/A Lactobacillus
crispatus
VCU_NT40 0.26 + Bacterial vaginosis African American 8 ND Sneathia amnii
VCU_NT733 0.20 + None African American 5.8 ND Lactobacillus iners
VCU_NT88 0.20 2 None African American 4 N/A Lactobacillus iners
VCU_XP87 0.15 + Trichomoniasis, Bacterial vaginosis African American ND 2 BVAB1
VCU_NT89 0.13 2 Bacterial vaginosis African American 4.5 N/A Streptococcus
agalactiae
VCU_NT07 0.13 2 None Hispanic ND N/A Lactobacillus iners
VCU_NT26 0.12 + Bacterial vaginosis Other (Multiracial) 5 ND Gardnerella
vaginalis
VCU_NT62 0.11 ND Bacterial vaginosis African American 5.3 N/A Gardnerella
vaginalis
VCU_NT91 0.10 2 None Caucasian 4 N/A Lactobacillus iners
‘‘Ca. M. girerdii’’ was detected in the mid-vaginal microbiome profile at 0.1% or more of total reads. (ND, not determined; AMB, ambiguous; N/A, not applicable; NT, no
type).
* Recruited from Labor & Delivery Unit.
{ ‘‘Ca. M. girerdii’’ sequenced genomes VCU-M1, VCU-JB1, VCU-PA1 and VCU-G1 in listed order.
1,2,3 Three ‘‘Ca. M. girerdii’’ positive samples were from women who enrolled in the study more than once. VCU_GF83 was collected 424 days after VCU_NT73;
VCU_NT58 was collected 246 days after VCU_NT70; VCU_NT77 was collected 117 days after VCU_RQ48.
doi:10.1371/journal.pone.0110943.t001
Trichomoniasis-Associated Mycoplasma
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reference strain, one putative CRISPR locus containing four 34-
nucleotide repeats and three 35-nucleotide spacers was identified
in the genome with a consensus direct repeat sequence of 59-
AAGTATTAATATTCCAAGTAGTGTAACTAGTATT.
Genes in the rRNA operon were organized 59-16S-23S-5S, and no
tRNAs were identified in the intergenic transcribed spacer regions
as with most Mycoplasma and Ureaplasma species [32]. Like other
mycoplasmas, ‘‘Ca. M. girerdii’’ possesses a minimal number of
tRNAs and utilizes UGA as a tryptophan codon. We identified 31
putative tRNAs: 11 amino acids represented by a single anticodon;
seven amino acids (Gly, Lys, Ser, Thr, Trp, Met) represented by
two anticodons; and two amino acids (Leu, Arg) represented by
three anticodons. Some, but not all, mycoplasmas have lost the
tRNA-Trp gene that utilizes the TGG codon[33], but ‘‘Ca. M.
girerdii’’ appears to have both. We identified two tRNA-Trp
genes, one that utilizes the UGA codon with an observed codon
frequency of ,0.87% and another that utilizes the TGG codon
with an observed codon frequency of ,0.13%. The dnaA and
dnaN genes are co-localized, but recF appears to be absent and
gyrB is only distantly linked. As with M. penetrans and U.
urealyticum [34], no clusters of DnaA boxes were identified
upstream of the dnaA gene, as only one 9-mer with two base
differences from the DnaA box consensus (59-TTATCCACA) was
identified in that region.
Homologs to putative virulence factors, including collagenases,
a hemolysin, an O-sialoglycoprotein endopeptidase, and a feoB-
like iron transport system, were identified in all four strains.
Intriguingly, tensile strength of fetal membranes is imparted by
collagens, and thus bacterial collagenase activity could facilitate
fetal membrane rupture. ‘‘Ca. M. girerdii’’ appears to lack the
superoxide dismutase gene, but encodes a complete desulfoferro-
doxin-type superoxide reductase system that likely functions to
protect against oxidative stress. A ,16 kb plasmid is apparently
present at approximately two copies per ‘‘Ca. M. girerdii’’ cell in
Table 2. Associations of vaginal carriage of bacterial taxa with common vaginal infections.
Relative Risk (95% Confidence Interval)
Trichomoniasis Bacterial vaginosis Yeast infection
‘‘Ca. M girerdii’’ 20.12 (7.75–48.34) 0.88 (0.24–1.53) 0.86 (0.00–1.98)
M. hominis 2.53 (0.85–6.83) 2.08 (1.61–2.68) 0.80 (0.44–1.30)
U. parvum/U. urealyticum 1.36 (0.40–3.49) 0.62 (0.45–0.84) 1.18 (0.74–1.75)
Gardnerella vaginalis 4.45 (0.91– Infinity*) 7.17 (4.05–21.78) 0.81 (0.54–1.32)
Atopobium vaginae 1.79 (0.70–9.10) 5.02 (3.50–8.43) 0.56 (0.35–0.83)
BVAB2 0.66 (0.17–1.80) 3.25 (2.54–4.30) 0.45 (0.22–0.75)
Bootstrap (n = 1,000) samples were selected from the outpatient clinic population to reflect the outpatient community composition. Median relative risk and 95%
bootstrap confidence intervals are shown. A bacterial taxon was considered present in the mid-vaginal sample if at least 0.1% of the metagenomic 16S rRNA gene
microbiome profile reads classified to the taxon. Vaginal infection was determined by clinical diagnosis using Amsel’s criteria for BV.
*For at least 2.5% of the bootstrap samples, all subjects with a trichomoniasis diagnosis were positive for G. vaginalis.
doi:10.1371/journal.pone.0110943.t002
Figure 1. Detection of ‘‘Ca. Mycoplasma girerdii’’ in mid-vaginal samples. Panel (A) shows relative abundance of major taxonomic groups in
‘‘Ca. M. girerdii’’ positive samples (1% 16S rRNA threshold): ‘‘Ca. M. girerdii’’ is colored red (A). Light colored bars represent other taxa. Dark blue circles
represent samples positive for T. vaginalis by qRT-PCR, light gray circles represent negative samples. Panels (B–E) show fluorescence in situ
hybridization detection of bacteria in mid-vaginal samples from two participants with clinically diagnosed trichomoniasis (subject 1, panels B, C and
D; subject 2, panel E) by confocal laser scanning microscopy. Most bacteria were detected with fluorescein-labeled broad-range bacteria probe
Eub338 (turquoise). ‘‘Ca. M. girerdii’’ was also stained with a Cy5-labeled probe targeting 16S rDNA (red). Nuclei were labeled with 4969-diamidine-2-
phenylindole, dehydrochloride (DAPI, blue). Negative control with reverse complementary probe of Eub338 did not hybridize to any bacteria (data
not shown). Scale bar = 10 mm.
doi:10.1371/journal.pone.0110943.g001
Trichomoniasis-Associated Mycoplasma
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the sample containing the reference strain, but was not observed in
the samples containing the other strains. It carries a plasmid
replication initiator protein, two genes resembling components of a
type IV secretion system and ,9 hypothetical genes. Because of its
prevalence in the former sample and its similarity to plasmids from
related organisms, it is possible that this may represent the first
plasmid associated with a mycoplasma in this phylogenetic group
(see below).
Phylogenetic analysis of 16S rRNA genes shows that ‘‘Ca. M.
girerdii’’ is most closely related to other uncultivated organisms
identified by 16S rRNA sequence: the organism reported by
Martin et al. [2], an organism identified by Costello et al. in oral
samples of a low birth weight neonate [16], and other organisms
from bovine rumen [35], the gut of termites [36–38] and Asiatic
elephant and Somali wild ass feces [39] (Figure 4). Interestingly,
the environments of the gut of lower termites, the rumen of cattle
and other foregut fermenters and the cecum of hindgut fermenters
Figure 2. Cluster analysis of mid-vaginal samples positive for ‘‘Ca. M. girerdii’’. Relative abundance of microbial taxa in mid-vaginal
bacterial communities of ‘‘Ca. M. girerdii’’ positive women is shown. The dendrogram was generated using Ward’s method with Manhattan distance.
This analysis includes only mid-vaginal samples that exhibited at least 0.1% ‘‘Ca. M. girerdii’’ by 16S rDNA profiling. Clinical diagnosis is indicated in
the first bar, and presence of T. vaginalis by RT-PCR is indicated in the second bar (orange designates a negative result and pink designates a positive
result). The three samples dominated by L. crispatus and the three samples with the highest prevalence of L. iners were negative for T. vaginalis.
doi:10.1371/journal.pone.0110943.g002
Table 3. ‘‘Ca. M. girerdii’’ is associated with African American race and elevated vaginal pH.
African American race Caucasian race Mid-vaginal pH
‘‘Ca. M. girerdii’’ 88.0/74.8(0.003*) 6.9/17.6(1) 5.5/5.0(0.006*)
Mycoplasma hominis 89.4/70.1(0*) 6.2/21.2(1) 5.5/5.0(0*)
Ureaplasma spp. 75.1/75.3(0.555) 17.0/17.2(0.571) 5.0/5.0(0.514)
Gardnerella vaginalis 81.5/59.2(0*) 11.9/30.8(1) 5.3/4.6(0*)
Atopobium vaginae 85.6/62.2(0*) 8.8/27.6(1) 5.3/4.6(0*)
BVAB2 88.1/69.0(0*) 6.5/22.3(1) 5.5/5.0(0*)
Mean proportions of the most common racial groups and median values for mid-vaginal pH were calculated for carriers and non-carriers (i.e., 0.1% 16S rRNA
microbiome threshold) of the genital mycoplasmas and representative BV-associated species of women recruited from 1,361 women recruited from outpatient clinics.
Bootstrap analysis was performed so that values represent the underlying population of the clinic.
*Bootstrap probabilities (n = 1,000) less than 0.05 indicate that the mean proportion or median value is significantly higher for carriers of the species.
doi:10.1371/journal.pone.0110943.t003
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(e.g., Asiatic elephant and Somali wild ass) are all models of
symbiosis where diverse groups of organisms including bacteria
and protozoa contribute to carbohydrate fermentation and benefit
the host by assisting with plant digestion.
A phylogenetic analysis using 57 inferred orthologous proteins
placed ‘‘Ca. M. girerdii’’ in the Pneumoniae group with M.
penetrans and Mycoplasma iowae, relatively distant from M.
hominis (Figure 5). This phylogeny is supported by analysis.
Analysis of COGs distributed 415 of the ‘‘Ca. M. girerdii’’ genes
among functional categories in a pattern similar to that exhibited
by other mycoplasma species (Table S1). The full-length ‘‘Ca. M.
girerdii’’ 16S rRNA gene from all four genomes and ‘‘Mnola’’
exhibited 100% identity.
Metabolic strategies of ‘‘Ca. M. girerdii’’
Genital mycoplasmas have evolved to utilize various energy
sources; M. genitalium, M. hominis, and ureaplasmas use glucose,
arginine and urea respectively. Our metabolic reconstructions
suggest that ‘‘Ca. M. girerdii’’ is glycolytic like M. genitalium and
encodes all enzymes for utilization of glucose as an energy source
(Figure 6). Arginine dihydrolase pathway and urease genes are
absent, thus ‘‘Ca. M. girerdii’’ is not predicted to utilize arginine
and urea. Catabolism of galactose, mannose, sucrose, maltose,
glycogen, starch or glycerol is not predicted, and the roles of genes
in the lactose/galatose pathways are unclear. ‘‘Ca. M. girerdii’’
possesses genes for a putative IIA component of the lactose-specific
phosphotransferase system (MGM1_4770), ribose/galactose-ABC-
type transporter system (MGM1_3070, MGM13080) and a
galactose-6-phosphate isomerase (MGM1_4760/MGM1_4750).
However, other genes required for lactose and galactose catabo-
lism, including 6-phospho-beta-galactosidase, tagatose-6-phos-
phate kinase and tagatose-bisphosphate aldolase, were not
identified. Moreover, the L-lactate dehydrogenase gene
(MGM1_4130) has an apparent frameshift. Other components
of the phosphotransferase system (PTS) system were also
identified, including the HPr phosphocarrier protein
(MGM1_1420) and an HPr phosophatase/kinase
(MGM1_4210), which likely functions in the regulation of carbon
metabolism. While all eight subunits for the F1F0 ATPase
complex were identified (MGM1_4310 through MGM1_4380),
these genes are thought to be involved in maintenance of the
proton gradient rather than ATP generation in mycoplasma
species as the cytochrome components are absent.
Unique among the genital mycoplasmas, the ‘‘Ca. M. girerdii’’
genome encodes serine dehydratase (MGM1_2560, MGM1_0390),
alanine dehydrogenase (MGM1_5480, MGM1_1820), and 29,39-
cyclic-nucleotide 29-phosphodiesterase (MGM1_1930) that may
permit use of alternate energy sources in the absence of glucose: L-
alanine, L-serine, and 29,39 cyclic AMP. No serine dehydratases
have been previously described for the mollicutes, and while alanine
dehydrogenase has been described for Acholeplasma laidlawii [40]
and annotated for M. mycoides (ADH22225.1), M. mobile
(AAT27586.1), M. leachii (ADR24467.1), and M. putrefaciens
(YP_004790384.1), neither the gene nor the enzyme has been
previously identified in any of the genital mycoplasmas or organisms
classified in the Pneumoniae group. Moreover, 29,39-Cyclic
phosphodiesters may be available in the environment as interme-
diate products in the hydrolysis of RNA by ribonuclease I. This
strategy has been proposed for Yersinia enterocolitica [41], which
has been shown to grow on 29,39-cAMP as a sole carbon source.
‘‘Ca. M. girerdii’’ does not metabolize pyruvate through the
pyruvate dehydrogenase pathway that is used by M. genitalium or
the other mycoplasma species that catabolize pyruvate to acetate.
However, ‘‘Ca. M. girerdii’’ may utilize one or both of two alternate
enzymes identified in the genome: pyruvate-formate lyase
(MGM1_5430), which produces acetyl-CoA and formate from
CoA and pyruvate, and/or pyruvate ferredoxin/flavodoxin oxido-
reductase (MGM1_5310), which yields acetyl-CoA and carbon
dioxide from the same substrates by reducing either ferredoxin or
flavodoxin. Both of these enzymes seem to be unique to ‘‘Ca. M.
girerdii’’ among the mycoplasmas. Acetyl-CoA may be converted to
acetate by phosphate acetyltransferase (MGM1_0120) and acetate
kinase (MGM1_2290), resulting in the production of ATP.
As with other mollicutes, ‘‘Ca. Mycoplasma girerdii’’ appears to
have limited metabolic capabilities and imports much of what it
needs from its environment or host. ‘‘Ca. M. girerdii’’ seems to
lack gluconeogenesis and the TCA cycle like other mycoplasmas.
It lacks enzymes for de novo purine or pyrimidine synthesis and
amino acid synthesis, but appears to be capable of nucleotide
salvage and amino acid transport. The genome encodes ,40
genes associated with transport of various ions and substrates
including amino acids, glucose, ribose/lactose, potassium ion,
magnesium ion, calcium ion, ferrous iron, cobalt, phosphate and
Figure 3. Representation of ‘‘Ca.M. girerdii’’ genomes. A circular
representation of the ‘‘Ca. M. girerdii’’ reference genome (strain
VCU_M1) assembled from metagenomic sequences from a mid-vaginal
sample. Position 1 is set to the start of the dnaA gene. Outermost circles
(1–3) show the alignment (97% or greater identity) of contigs of three
different strains from metagenomic assemblies from mid-vaginal
samples containing high proportions of ‘‘Ca. M. girerdii’’. Circle 4 (red)
represents the reference strain (VCU_M1). Circles 5 (dark red) and 6
(blue) represent the predicted coding sequences in the forward and
reverse orientations respectively. Circle 7 (black) shows the GC content,
and circle 8 shows GC skew (pink (-), green (+)).
doi:10.1371/journal.pone.0110943.g003
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spermidine/putrescine (Table S2). An alcohol dehydrogenase
(MGM1_5890) exhibiting homology to a butanol dehydrogenase
and putative bifunctional aldehyde-alcohol dehydrogenase
(MGM1_1150) were also annotated in the genome, thus ethanol
may also be an end product of metabolism. Although ‘‘Ca. M.
girerdii’’ is predicted to be able to convert butanol to butanoyl-
CoA, it appears to lack other enzymes of butanoate metabolism.
Figure 4. Phylogenetic tree of 16SrRNA shows uncultured ‘‘Ca.M. girerdii’’ clusters most closely with other uncultivated organisms
in the Pneumoniae Group. The maximum likelihood tree was inferred by RAxML 7.2.7 using the gamma-distributed heterogeneity rate categories
with 1,000 bootstraps. The 16S rRNA gene alignments were manually inspected. The Hominis Group is shaded in blue, the Pneumoniae Group in
green, the Hemoplasma Group in gray and the Spiroplasma Group in purple. The 16S rRNA sequence of ‘‘Ca. M. girerdii’’ VCU_M1, ‘‘Ca. M. girerdii’’
VCU_PA1, ‘‘Ca. M. girerdii’’ VCU JB1 and ‘‘Ca. M. girerdii’’ VCU_G1 were identical. ‘‘Ca. M. girerdii’’ groups most closely with ‘‘Mnola’’, which shows
100% identity in 16S rRNA sequence, uncultivated organisms from the oral sample of a low birth weight infant (HG764209, HG764210, and
HG764212) and uncultivated species from rumen and termite gut in the Pneumoniae Group. A partial 16S rRNA sequence from the vaginal sample of
a woman who delivered full term (JX871253) also exhibits 99% identity with ‘‘Ca. M. girerdii’’, but was not included in the analysis due to its length.
doi:10.1371/journal.pone.0110943.g004
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The predicted metabolic reconstruction may provide insight and
help guide future cultivation attempts.
BspA-like proteins encoded in ‘‘Ca. M. girerdii’’
Mycoplasma species contain surface proteins that exhibit high
frequency antigenic variation [42]. Although these organisms
exhibit a low level of horizontal gene transfer, expanded families of
surface proteins are an exception [43–45]. In the reference
genome of ‘‘Ca. M. girerdii’’, we identified a family of 26 BspA-
like proteins containing Treponema pallidum leucine rich repeat
(TpLRR) domains with homology to the prototypical BspA
virulence factor of Tannerella forsythia and a family of over 900
BspA-like proteins of T. vaginalis [46,47]. BspA-like proteins from
‘‘Ca. M. girerdii’’ exhibit variable length ranging in length from
136 to 1481 amino acids (Figure 7). Twenty-three of the BspA-like
proteins contained a predicted C-terminal transmembrane
domain, and a signal peptide was detected for five of the BspA-
like proteins.
Members of this family stimulate a Toll-like receptor 2 (TLR2)-
mediated host immune response. We also identified two other
putative surface lipoproteins that lack the TpLRR domain, but
exhibit homology to other mycoplasma proteins that stimulate a
TLR-mediated innate immune response. It is intriguing to
hypothesize that the expanded families of BspA-like proteins in
the ‘‘Ca. M. girerdii’’ and T. vaginalis may represent a common
host-adaptation strategy.
The BspA from T. forsythia is perhaps the best studied protein
containing the TpLRR domain. This protein has been shown to
mediate a host innate immune response through Toll-like receptor
2 (TLR2 [48]) by directly interacting with the receptor [49]. More
recently, the protein has been shown to elicit a response through
scavenger receptor gp340 [50]. T. forsythia BspA has also been
shown to be required for host cell attachment and invasion [51]
and co-aggregation with Fusobacterium nucleatum [51]. Thus, the
‘‘Ca. M. girerdii’’ BspA-like proteins may also mediate interactions
with the host and contribute to virulence through induced host
inflammation.
No TpLRR-containing proteins have been identified in U.
parvum, U. urealyticum or M. genitalium and only one or two
predicted BspA-like proteins were identified in the other related
genomes examined: one in M. iowae (ZP_08916569.1), one in M.
fermentans (YP_003922737.1 and YP_003922552.1), two in M.
hominis (YP_003302763.1; YP_003303010.1) and one in M.
penetrans (NP_757414.1). Although the role of the 26 member
BspA-like gene family in ‘‘Ca. M. girerdii’’ is currently unclear, it is
likely that they have important functions in host interactions. It is
intriguing to hypothesize that the TpLRR domains of the BspA-
like proteins from M. hominis, T. vaginalis, and ‘‘Ca. M. girerdii’’,
which appear to be absent in the Ureaplasma species and M.
genitalium genomes, may interact with the human host cells in a
similar manner via the TLR2 receptor.
Conclusions
In summary, we confirmed the identity of a recently described
and still uncultivated species of mycoplasma, further documented
its strong association with the presence of T. vaginalis, and
comprehensively characterized the genomes of ‘‘Ca. M. girerdii’’
from four vaginal samples collected in the Vaginal Human
Figure 5. Phylogenetic Tree based on inferred amino acid sequences confirms placement of ‘‘Ca. M. girerdii’’ in the Pneumoniae
group. ‘‘Ca. M. girerdii’’ is located within the Pneumoniae group, denoted in green, in a subclade along with the Ureaplasma species, M. iowae and
M. penetrans. The tree was inferred using amino acid sequences of 57 orthologs (Tables S4, S5, and S6). Numbers at nodes correspond to the support
values from 1,000 bootstrap replicates.
doi:10.1371/journal.pone.0110943.g005
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Microbiome Project at VCU. The genomes of this potentially
emerging pathogen provide insight into its metabolic strategies and
reveal a potential for virulence and for triggering host inflamma-
tory responses through innate immune mechanisms. This work
lays the foundation for understanding the impact of ‘‘Ca. M.
girerdii’’ on women’s urogenital health and the nature of its
association with T. vaginalis.
Figure 6. Unique strategies of ‘‘Ca. M. girerdii’’. Putative transporters, enzymes involved in carbohydrate metabolism and virulence factors are
represented in red for ‘‘Ca. M. girerdii’’. Comparisons with other genital mycoplasmas are indicated with color-coded boxes: M. genitalium (MG, blue)
U. parvum (UP, green) and M. hominis (MH, purple). Arrows indicate direction of transport. Light gray arrows represent metabolic strategies unique to
other genital mycoplasma. Metabolic reconstruction was performed using ASGARD and careful inspection of manual annotations.
doi:10.1371/journal.pone.0110943.g006
Figure 7. Expanded ‘‘Ca. M. girerdii’’ BspA-like protein family. The diverse family of 26 BspA-like protein family members from the ‘‘Ca. M.
girerdii’’ strain VCU_M1 is depicted in panel (A). Predicted transmembrane domains and TpLRR domains are represented. An alignment of TpLRR
domains from Tannerella forsythia BspA (AAC82625.1, bases 382–1347), ‘‘Ca. M. girerdii’’ strain VCU_M1 MGM1_3780 (bases 449–782) and T.vaginalis
BspA-like TVAG_495790 (XP_001327783.1, bases 112–1077) is shown in panel (B).
doi:10.1371/journal.pone.0110943.g007
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Description of ‘‘Candidatus Mycoplasma girerdii’’
‘‘Candidatus Mycoplasma girerdii’’ [gir.erdii. N.L. gen. n.
girerdii, named for P.H. Girerd, an American obstetrician and
gynecologist, for his dedication to clinical practice and his
contributions to the research of the vaginal microbiota].
Materials and Methods
Identification of ‘‘Ca. M. girerdii’’
Mid-vaginal swab samples collected from women at 1,471 visits
(1,361 outpatient visits, 110 visits to the labor and delivery unit)
were assayed by 16S rRNA gene pyrosequencing according to the
protocols of the Vaginal Human Microbiome Project at VCU
[18,52]. The team that performed the PCR was blinded to the BV
and T. vaginalis diagnoses and results. Mid-vaginal pH, clinical
diagnosis and health history were recorded. The teams that
recorded and digitally entered this information were blinded to the
PCR and RT-PCR results. Clinical diagnosis of trichomoniasis
was based on identification of motile trichomonads in a saline wet
mount preparation of vaginal discharge. BV was clinically
diagnosed in women meeting at least three of Amsel’s four criteria
[19]: characteristic BV discharge, clue cells on microscopy, vaginal
pH .4.5 and positive whiff test. Consent was obtained from all
participants in accordance with the study protocol (HM12169) as
approved by the institutional review boards for human subjects
protection at Virginia Commonwealth University and the Virginia
Department of Health Raw sequence data from the project is
available from the Short Read Archive at NCBI (projectID
phs000256).
Fluorescence in situ hybridization
Vaginal swabs were resuspended in phosphate buffered saline
(PBS) and incubated on poly L-lysine coverslips (BD Biosciences,
San Jose, CA) in a 24-well tissue culture plate for 30 min at 37uC.
Coverslips were washed with PBS, fixed in 4% paraformaldehyde/
PBS for 1 h, and permeabilized with 0.2% TritonX-100/PBS for
10 min. Fifty nanograms of fluorescently labeled probe targeting
bacterial 16S rRNA was added to 200 ml of pre-warmed
hybridization buffer (0.9 M NaCl, 20 mM Tris-HCl (pH 7.2),
10% formamide, 0.01% SDS). Hybridization was carried out at
45uC for at least 2 h. Fluorescein-labeled broad range bacteria
probe Eub338 (59GCTGCCTCCCGTAGGAGT-39) was used as
a control. A Cy5-labeled specific probe (59-TCCTCTTAGTG-
CCGTTCGTCC-39) was used to detect ‘‘Ca. M. girerdii’’.
Following hybridization, coverslips were rinsed with pre-warmed
hybridization wash buffer (0.45 M NaCl, 20 mM Tris-HCl (pH
7.2), 0.01% SDS) then incubated in the wash buffer for 15 min at
48uC. Immediately following, coverslips were washed with ice-cold
distilled H2O, dried for 15 min at 48uC and mounted with
ProLong Gold Antifade containing 49,6-Diamidino-2-phenylin-
dole (DAPI) (Invitrogen, Carlsbad, CA). Slides were visualized by
laser scanning confocal microscopy using a Zeiss LSM 700.
Detection and genotyping of T. vaginalis
Detection of T. vaginalis by quantitative real-time RT-PCR
was performed as described by Shirm et al. [53], and T. vaginalis
genotyping was performed using three single-copy genes as
described by Conrad et al. [23,24].
Relative Risk Analysis
Bootstrap (n = 1,000) samples were selected from the outpatient
clinic population to reflect the outpatient community composition.
Samples from women enrolled in labor and delivery were not
included in this analysis. Median relative risk and 95% bootstrap
confidence intervals were calculated. A bacterial taxon was
considered present in the mid-vaginal sample if at least 0.1% of
the metagenomic 16S rRNA gene microbiome profile reads
classified to the taxon.
Metagenomic assembly of ‘‘Ca. M. girerdii’’
We selected one mid-vaginal sample (VCU_NT41; Table 1)
with .90% of 16S rRNA reads classified to ‘‘Ca. Mycoplasma
girerdii’’ from which to assemble the reference genome of the
organism. The woman who provided this sample was in active
preterm labor and also tested positive for group B Streptococcus
(GBS), Chlamydia trachomatis and T. vaginalis.
Fifty nanograms of total DNA was used in a tagmentation
reaction with a Nextera DNA Sample Prep Kit (Roche Titanium-
compatible, Epicentre Biotechnologies) following the manufactur-
er’s protocol and sequenced in the Nucleic Acids Research
Facilities at VCU. Titanium FLX pyrosequencing (Roche/454; 1/
2 plate) yielded 793,732 reads and 241,486,162 bases. The raw
data was pre-filtered to remove most human reads (55% of the
total reads) using Bowtie 2 [54] with default parameters. The reads
were then split into two bins using AbundanceBin [55]: (1) a bin
containing abundant reads including those derived from ‘‘Ca. M.
girerdii’’, and (2) a bin containing less abundant reads derived
from the minor components of the vaginal microbiome. Human-
filtered reads from the bin of abundant sequences (i.e., 252,073
reads, 79,029,547 bases) were assembled using Newbler, resulting
in 298 contigs larger than 500 bases and 1,966 contigs larger than
100 bases, with a total of 89.10% of reads aligned to a contig.
Through a careful analysis of the single-end read flow information
from Newbler, we inferred a circular scaffold for the organism that
incorporated 19% (152,023 total reads) of the total unfiltered reads
from the metagenomic sample. The scaffold incorporated eight of
the largest ten contigs that ranged in size from 144,547 bases to
4,826 bases and exhibited 67.2-fold to 95-fold coverage. Sequence
reads incorporated into the ‘‘Ca. M. girerdii’’ genome did not map
to known Mycoplasma or Ureaplasma sequences, and no other
unnamed mollicutes were detected in these samples by 16S rRNA
analysis. The eighth-largest contig encoded a 16kb plasmid with
an observed depth of 189-fold coverage. Because of its abundance,
it is likely that this plasmid is from ‘‘Ca. M. girerdii’’ but the host of
the plasmid cannot yet been unequivocally assigned. The ninth-
largest contig aligned to T. vaginalis ribosomal RNA genes. An
additional eight smaller contigs ranging in size from 161 bases to
814 bases were also incorporated into the scaffold, with two of the
contigs incorporated twice. The majority of non-assembled contigs
aligned to T. vaginalis (232 contigs), Homo sapiens (21 contigs), or
other bacterial species; e.g., Gardnerella vaginalis (10 contigs).
Physical gaps in the contig junctions were confirmed and closed by
PCR across gaps and fluorescent chain termination sequence
analysis on the AB3730 or AB3130 capillary sequencers (Applied
Biosystems). These gaps commonly occurred either in genes
exhibiting homology to type I restriction modification system
proteins or those encoding BspA-like proteins, although one
junction spanned a gene encoding a signal recognition particle
protein, which was present in only one copy. PCR and sequencing
primers are provided (Table S3). All physical gaps in the scaffold
were closed by PCR-amplification and sequencing using the
Sanger capillary methodology. The circularity of the 16kb plasmid
was similarly confirmed.
Three additional mid-vaginal samples (VCU_CT62,
VCU_NT44, VCU_NT71; Table 1) each containing more than
30% ‘‘Ca. M. girerdii’’ by metagenomic 16S rRNA gene
microbiome analysis were also sequenced by whole metagenome
shotgun sequencing using Titanium FLX pyrosequencing and the
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protocol described above. Each sample was run on approximately
one eighth of a plate, yielded between 185,612 and 222,667 total
reads and assembled using Newbler, and aligned to the reference
strain. The genomes of ‘‘Ca. M. girerdii’’ have been deposited with
NCBI under the Bioproject accession numbers PRJNA196996,
PRJNA196997, PRJNA196998, and PRJNA196999. The com-
plete genome of ‘‘Ca. M. girerdii’’ has been deposited at NCBI
under accession number CP007711.
Genome annotation and metabolic reconstruction
Open reading frames (ORFs) greater than 100 nucleotides were
predicted by Glimmer3 [56] and GeneMarkS [57] using
translation table 4 and were manually examined. In most cases
the start site predicted by Glimmer3 was chosen for genes that had
the same predicted stop codon called by both Glimmer3 and
GeneMarkS. Translated ORF predictions were searched against
the non-redundant (nr) database from NCBI and a custom
database of Mollicute proteins downloaded from NCBI using the
blastp algorithm, and the gene products were manually annotated.
Predicted gene products were compared to conserved domain
databases (COGs and Pfam) by RPS-BLAST. Other annotation
features were predicted using TMHMM 2.0c [58] for transmem-
brane domains and SignalP 4.0 for signal peptides. Although
mollicutes have a unique membrane composition, SignalP has
been previously validated on experimentally verified secreted
proteins from mollicutes [59]. The hmmsearch program from
HMMER3.0 [60] was used to search predicted proteins for the
Treponema palladium family of leucine rich repeats (TpLRR)
using the Pfam raw hidden markov model for the family (LRR_5;
PF13306). Transfer RNA genes were predicted by tRNAscan-SE v
1.3 using the genetic code outlined in translation table 4. The
tRNA-Ile, elongator tRNA-Met and initiator tRNA-fMet were
distinguished by alignment with previously annotated tRNAs [61].
The CRISPR element containing four 34-nucleotide repeats and
three 35-nucleotide spacers was identified in the genome with a
consensus direct repeat sequence of 59-AAGTATTAATATTC-
CAAGTAGTGTAACTAGTATT using the CRISPR recognition
tool (CRT) [62]. Metabolic reconstruction and Gene Ontology
classification assignments were performed using ASGARD [63]
and the UniRef100 database.
Phylogenetic analysis
One reference genome was selected for each species in the
Mollicutes class for which a completely sequenced genome is
available. A total of 57 transitively closed orthologous clusters were
retrieved from the RoundUp [64] database (release date: Dec. 23,
2011). ‘‘Ca. M. girerdii’’ orthologs were identified using blastp and
confirmed using the Reciprocal Smallest Distance (RSD) algo-
rithm. Orthologs were similarly identified for M. iowae for which
only a draft genome is available. The maximum-likelihood tree
was inferred by RAxML 7.2.74 [65] using the gamma-distributed
heterogeneity rate categories with 1,000 bootstraps. The tree was
rooted using Lactobacillus gasseri as the outgroup. Phylogenetic
trees based on 16S rDNA gene sequences were similarly
constructed. The 16S rRNA gene alignments were manually
inspected and the maximum likelihood tree was inferred by
RAxML 7.2.74 using the gamma-distributed heterogeneity rate
categories with 1,000 bootstraps.
Attempts to cultivate ‘‘Ca. M. girerdii’’
Frozen vaginal swab samples were incubated on A8 and SP4
agar (Hardy Diagnostics). When these plates did not yield colonies,
the frozen samples were cultured on PPLO broth base containing
10% horse or 10% human serum, 10% yeast extract, 1% arginine
and 1.5% Bacto agar [66]. The samples were also incubated on
supplemented BHI agar [67] containing 10% human blood. All
solid media was supplemented with 100 mg ampicillin/mL and
plates were incubated at 37uC under anaerobic conditions and in
air supplemented with 5% CO2. None of these efforts yielded
detectable growth.
Ethics Statement
Consent was obtained from all participants in accordance the
study protocol as approved by the institutional review boards for
human subjects protection at Virginia Commonwealth University
and the Virginia Department of Health. All enrolled subjects were
18 years of age or older and provided written informed consent.
Supporting Information
Figure S1 Cluster analysis of mid-vaginal samples with
a clinical diagnosis of trichomoniasis. Relative abundance
of microbial taxa in mid-vaginal bacterial communities of 63
women with clinically diagnosed trichomoniasis is shown. The
dendrogram was generated using Ward’s method with Manhattan
distance. Presence of ‘‘Ca. M. girerdii’’ as determined by 16S
rDNA profiling is indicated in the top bar. Samples that contained
‘‘Ca. M. girerdii’’ at less than 0.1% abundance are indicated as
ambiguous (AMB) in light blue.
(PDF)
Figure S2 Detection of ‘‘Ca. M. girerdii’’ in mid-vaginal
samples. Fluorescence in situ hybridization detection of bacteria
in mid-vaginal samples from two participants with clinically
diagnosed trichomoniasis (subject 1, panels A–O); subject 2, panels
P–T) by confocal laser scanning microscopy. The merged
photomicrographs are also depicted in Figure 1. Nuclear DNA
was detected with 4969-diamidine-2-phenylindole, dehydrochlor-
ide (DAPI, blue) as shown in panel B, G, L and Q. Most bacteria
were detected with fluorescein-labeled broad-range bacteria probe
Eub338 (green) as shown in panels C, H, M and R. ‘‘Ca. M.
girerdii’’ was also stained with a Cy5-labeled probe targeting 16S
rDNA (red) as shown in panels D, I, N and S.
(PDF)
Figure S3 ‘‘Ca. M. girerdii’’ coexists with both geno-
types of T. vaginalis. The maximum likelihood tree was
constructed using concatentated, aligned partial protein sequences
from three single-copy orthologs (CRN, PMS1, Mlh1a). Isolates
indicated as type 1 or type 2 were previously typed using
microsatellite markers. Strains from 43 clinically diagnosed cases
of trichomoniasis from this study are indicated with the prefix
‘‘VCU’’. The type 1 cluster is shaded blue and contains eight ‘‘Ca.
M. girerdii’’ positive cases, the type 2 cluster is shaded green and
contains ten ‘‘Ca. M. girerdii’’ positive cases and the ambiguous
cluster is shaded gray and contains five ‘‘Ca. M. girerdii’’ positive
cases. In this analysis, the ambiguous cluster groups with type 2 T.
vaginalis, but the subgroup contains isolates that were differen-
tially classified as type 1 using microsatellite markers. T. vaginalis
strains from ‘‘Ca. M. girerdii’’ positive cases as determined by 16S
rRNA microbiome profiling (0.1% threshold) are indicated with
red boxes. Ambiguous cases that were detected at less than 0.1%
threshold are denoted with pink boxes. Blue dots denote branches
with bootstrap values greater than 50.
(PDF)
Figure S4 Conserved synteny among ‘‘Ca. M. girerdii’’
strains not shared with related species. Panel (A) shows dot
plot nucleotide-based alignments of the reference ‘‘Ca. M.
girerdii’’ strain VCU_M1 with contigs from three different ‘‘Ca.
Trichomoniasis-Associated Mycoplasma
PLOS ONE | www.plosone.org 12 October 2014 | Volume 9 | Issue 10 | e110943
M. girerdii’’ strains (VCU_PA1, VCU_JB1, VCU_G1). Panel (B)
shows dot plot amino-acid based alignments of the reference with
three closely related species (M. iowae, M. penetrans and U.
parvum). Horizontal grid lines delineate contigs. Nucleotide-based
and protein-based alignments were performed using Nucmer and
Promer respectively.
(PDF)
Table S1 Distribution of Clusters of Orthologous
Groups (COGS).
(DOCX)
Table S2 Putative transporters in ‘‘Ca. M. girerdii’’
strain VCU_M1.
(DOCX)
Table S3 List of primers for circularization of ‘‘Ca. M.
girerdii’’ genome.
(DOCX)
Table S4 Hominis Group orthologs.
(DOCX)
Table S5 Pneumoniae and Hemoplasma Group ortho-
logs.
(DOCX)
Table S6 Spiroplasma, Phytoplasma and Outgroup
orthologs.
(DOCX)
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